Literature DB >> 1628895

Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.

S J Challacombe1, D Rahman, H Jeffery, S S Davis, D T O'Hagan.   

Abstract

Intragastric immunization may lead to the induction of antibodies in the secretory immune system including saliva. The antibody response is usually short-lived. The objectives of this study were to see whether oral immunization with biodegradable microparticles containing antigen might lead to enhanced mucosal responses. Ovalbumin (OVA) was entrapped in a novel antigen delivery system comprising poly (D,L-lactide-co-glycolide) (PLGA) microparticles. Salivary IgA and serum IgG responses after three daily oral immunizations in BALB/c mice were assayed by ELISA at weekly intervals and compared with those to soluble antigen. Low levels of salivary IgA antibodies were detected at Weeks 2 and 3 in both groups and no significant differences were found. After a secondary series of intragastric immunizations at Week 4, marked differences were apparent between the groups. The mean salivary IgA titre at Week 6 was 959 +/- 494 U compared with 30 +/- 5 in the soluble OVA group (P less than 0.0001). Significant differences were still apparent at Weeks 7-8 through the value was falling. Serum IgG antibodies were detectable and were significantly greater in the particle group (at Weeks 4 and 8) than in controls (P less than 0.001). These results suggest that microparticles are taken up by antigen-presenting cells in Peyer's patches, then slowly degrade in vivo and release entrapped antigens, and thus can function as potent antigen delivery systems giving rise to both mucosal and systemic responses. Microparticles have considerable potential as a controlled released antigen delivery system for the induction of longer-term immune responses at mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628895      PMCID: PMC1421730     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Antibody-forming cells in human colostrum after oral immunisation.

Authors:  R M Goldblum; S Ahlstedt; B Carlsson; L A Hanson; U Jodal; G Lidin-Janson; A Sohl-Akerlund
Journal:  Nature       Date:  1975-10-30       Impact factor: 49.962

2.  Biodegradable microspheres as a vaccine delivery system.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; J R McGhee; T R Tice; R M Gilley
Journal:  Mol Immunol       Date:  1991-03       Impact factor: 4.407

3.  Controlled release microparticles for vaccine development.

Authors:  D T O'Hagan; H Jeffery; M J Roberts; J P McGee; S S Davis
Journal:  Vaccine       Date:  1991-10       Impact factor: 3.641

4.  Tissue response to biodegradable injectable microcapsules.

Authors:  G E Visscher; M A Robison; G J Argentieri
Journal:  J Biomater Appl       Date:  1987-07       Impact factor: 2.646

5.  Secretory antibody following oral influenza immunization.

Authors:  R H Waldman; J Stone; K C Bergmann; R Khakoo; V Lazzell; A Jacknowitz; E R Waldman; S Howard
Journal:  Am J Med Sci       Date:  1986-12       Impact factor: 2.378

6.  Glycoconjugate receptors for bacteria attaching to mucosal sites: examples for Escherichia coli and Streptococcus pneumoniae.

Authors:  C Svanborg Eden; B Andersson; G Aniansson; H Leffler; H Lomberg; J Mestecky; A E Wold
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

7.  Microparticles as potentially orally active immunological adjuvants.

Authors:  D T O'Hagan; K Palin; S S Davis; P Artursson; I Sjöholm
Journal:  Vaccine       Date:  1989-10       Impact factor: 3.641

8.  Vaccines for the Third World.

Authors:  B R Bloom
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

9.  A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid.

Authors:  E L Parr; M B Parr
Journal:  J Reprod Fertil       Date:  1990-07

10.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more
  30 in total

1.  Surface expression of the conserved C repeat region of streptococcal M6 protein within the Pip bacteriophage receptor of Lactococcus lactis.

Authors:  B L Geller; N Wade; T D Gilberts; D E Hruby; R Johanson; L Topisirovic
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

Review 2.  Recent advances in vaccine adjuvants.

Authors:  Manmohan Singh; Derek T O'Hagan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

3.  Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  K Allaoui-Attarki; S Pecquet; E Fattal; S Trollé; E Chachaty; P Couvreur; A Andremont
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 4.  The intestinal uptake of particles and the implications for drug and antigen delivery.

Authors:  D T O'Hagan
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

Review 5.  Particle uptake and translocation across epithelial membranes.

Authors:  N W Thomas; P G Jenkins; K A Howard; M W Smith; E C Lavelle; J Holland; S S Davis
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

6.  Targeting to intestinal M cells.

Authors:  M A Jepson; M A Clark; N Foster; C M Mason; M K Bennett; N L Simmons; B H Hirst
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

Review 7.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

8.  The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique.

Authors:  H Jeffery; S S Davis; D T O'Hagan
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 9.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

10.  Hochuekkito, a Kampo (traditional Japanese herbal) Medicine, Enhances Mucosal IgA Antibody Response in Mice Immunized with Antigen-entrapped Biodegradable Microparticles.

Authors:  Tsukasa Matsumoto; Masaaki Noguchi; Osamu Hayashi; Kimiko Makino; Haruki Yamada
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.